You have 9 free searches left this month | for more free features.

City

Chengdu (1)

Shanghai (1)

Condition

COVID-19 Respiratory Infection (1)

Metastatic Castration Resistant Prostate Cancer (1)

mCRPC (1)

Overall Status

Completed (1)

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 3 (2)

phase 1 (1)

Sponsor

Hinova Pharmaceuticals Inc. (2)

Applied Biology, Inc. (1)

Collaborator

Hinova Pharmaceuticals Inc. (1)

West China Hospital (1)

Intervention

hc-1119 (3)

placebo (2)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

hc-1119

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

COVID-19 Respiratory Infection Trial (HC-1119, Placebo)

Not yet recruiting

COVID-19 Respiratory Infection

HC-1119
Placebo

(no location specified)

Feb 17, 2022

mCRPC Trial in Shanghai (HC-1119, )

Recruiting

mCRPC

HC-1119
placebo

Shanghai, China

Fudan University Shanghai Cancer Center

Aug 26, 2021

Metastatic Castration Resistant Prostate Cancer Trial in Chengdu (HC-1119)

Completed

Metastatic Castration Resistant Prostate Cancer

HC-1119

Chengdu, Sichuan, China

Hinova Pharmaceuticals Inc.

Oct 30, 2020